Drug Database
Back to search

Belgium· BE-AMP-SAM663950-00

Lyvdelzi 10 mg

A seladelpar product containing seladelpar lysine dihydrate, registered in Belgium by Gilead Sciences Ireland UC. The same ATC class is registered in 11 of our 19 countries.

ATC A05AX07

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLyvdelzi 10 mgATCA05AX07REGISTER NO.BE-AMP-SAM663950-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about seladelpar lysine dihydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Seladelpar is registered in 11 of 19 countries.

Countries holding a registration under ATC A05AX07 (seladelpar), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search seladelpar products by name

Seladelpar · ATC A05AX07

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Seladelpar Lysine Dihydrate
Manufacturer
Gilead Sciences Ireland UC
Country
Belgium (BE)
ATC code
A05AX07
ATC class
Seladelpar
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Seladelpar in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All seladelpar products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c0bace39-4beb-4773-b152-97ec59ee9d03
GET /v1/drugs/c0bace39-4beb-4773-b152-97ec59ee9d03?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Lyvdelzi 10 mg",
  "name_fr": "Lyvdelzi 10 mg",
  "name_nl": "Lyvdelzi 10 mg",
  "amp_code": "SAM663950-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "10.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Seladelpar Lysine Dihydrate",
    "Seladelpar",
    "Butylhydroxytoluene",
    "Mannitol",
    "Potassium Hydroxide",
    "Propylene Glycol",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Seladelpar",
  "authorisation_numbers": [
    "EU/1/24/1898/001",
    "EU/1/24/1898/002"
  ]
}
API referenceMCP serverPlans

See everything about seladelpar.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console